

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.04347604 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.04347604 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.68466726 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.68466726 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47147280 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.16904124 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.13552721 |
| 8 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.56359293 |
| 9 | bile acid biosynthetic process (GO:0006699) | 4.47682273 |
| 10 | regulation of cholesterol esterification (GO:0010872) | 4.47244199 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.41225266 |
| 12 | lysine catabolic process (GO:0006554) | 4.38303305 |
| 13 | lysine metabolic process (GO:0006553) | 4.38303305 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 4.37667064 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.36915908 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.35054707 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.35054707 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.35054707 |
| 19 | cysteine metabolic process (GO:0006534) | 4.34728977 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.27426521 |
| 21 | urea metabolic process (GO:0019627) | 4.24480354 |
| 22 | urea cycle (GO:0000050) | 4.24480354 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.14391421 |
| 24 | tryptophan metabolic process (GO:0006568) | 4.12329499 |
| 25 | plasma lipoprotein particle remodeling (GO:0034369) | 4.09178426 |
| 26 | protein-lipid complex remodeling (GO:0034368) | 4.09178426 |
| 27 | macromolecular complex remodeling (GO:0034367) | 4.09178426 |
| 28 | short-chain fatty acid metabolic process (GO:0046459) | 4.06298322 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.03946853 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 3.97812271 |
| 31 | fatty acid beta-oxidation (GO:0006635) | 3.95547276 |
| 32 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95162021 |
| 33 | acetyl-CoA metabolic process (GO:0006084) | 3.94096457 |
| 34 | plasma lipoprotein particle clearance (GO:0034381) | 3.92801546 |
| 35 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.91473120 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 3.89004982 |
| 37 | protein carboxylation (GO:0018214) | 3.88373996 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.88373996 |
| 39 | bile acid metabolic process (GO:0008206) | 3.87606123 |
| 40 | acylglycerol homeostasis (GO:0055090) | 3.86788860 |
| 41 | triglyceride homeostasis (GO:0070328) | 3.86788860 |
| 42 | reverse cholesterol transport (GO:0043691) | 3.86273237 |
| 43 | homocysteine metabolic process (GO:0050667) | 3.85517347 |
| 44 | valine metabolic process (GO:0006573) | 3.83947542 |
| 45 | glutamate metabolic process (GO:0006536) | 3.78186973 |
| 46 | tyrosine metabolic process (GO:0006570) | 3.78112866 |
| 47 | fatty acid oxidation (GO:0019395) | 3.75515112 |
| 48 | lipid oxidation (GO:0034440) | 3.72621531 |
| 49 | fatty acid catabolic process (GO:0009062) | 3.72240315 |
| 50 | regulation of protein activation cascade (GO:2000257) | 3.70427575 |
| 51 | serine family amino acid catabolic process (GO:0009071) | 3.69776078 |
| 52 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.68423536 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.67545971 |
| 54 | positive regulation of lipid catabolic process (GO:0050996) | 3.66156094 |
| 55 | aromatic amino acid family metabolic process (GO:0009072) | 3.65750616 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 3.64604699 |
| 57 | negative regulation of fibrinolysis (GO:0051918) | 3.64241024 |
| 58 | phospholipid efflux (GO:0033700) | 3.64024356 |
| 59 | nuclear pore complex assembly (GO:0051292) | 3.62452922 |
| 60 | monocarboxylic acid catabolic process (GO:0072329) | 3.58143600 |
| 61 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56612251 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.51294915 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.50590897 |
| 64 | nuclear pore organization (GO:0006999) | 3.50230801 |
| 65 | fatty acid homeostasis (GO:0055089) | 3.48362784 |
| 66 | regulation of complement activation (GO:0030449) | 3.48325482 |
| 67 | coenzyme catabolic process (GO:0009109) | 3.47564282 |
| 68 | regulation of sequestering of triglyceride (GO:0010889) | 3.47217923 |
| 69 | cholesterol biosynthetic process (GO:0006695) | 3.47106335 |
| 70 | phospholipid homeostasis (GO:0055091) | 3.46470094 |
| 71 | cholesterol efflux (GO:0033344) | 3.45751101 |
| 72 | ethanol oxidation (GO:0006069) | 3.44906618 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 3.42875288 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.41417167 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.37361049 |
| 76 | organic acid catabolic process (GO:0016054) | 3.35223620 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.35223620 |
| 78 | plasma lipoprotein particle organization (GO:0071827) | 3.34859475 |
| 79 | acyl-CoA biosynthetic process (GO:0071616) | 3.33981378 |
| 80 | thioester biosynthetic process (GO:0035384) | 3.33981378 |
| 81 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.33855634 |
| 82 | fatty acid transmembrane transport (GO:1902001) | 3.33839400 |
| 83 | negative regulation of lipase activity (GO:0060192) | 3.32806129 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 3.32104915 |
| 85 | carnitine metabolic process (GO:0009437) | 3.32015526 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.31258275 |
| 87 | negative regulation of sterol transport (GO:0032372) | 3.27203900 |
| 88 | negative regulation of cholesterol transport (GO:0032375) | 3.27203900 |
| 89 | very long-chain fatty acid metabolic process (GO:0000038) | 3.26823558 |
| 90 | branched-chain amino acid catabolic process (GO:0009083) | 3.26546997 |
| 91 | biotin metabolic process (GO:0006768) | 3.24234231 |
| 92 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.23431327 |
| 93 | positive regulation of fatty acid oxidation (GO:0046321) | 3.22584831 |
| 94 | sterol biosynthetic process (GO:0016126) | 3.20087172 |
| 95 | amine catabolic process (GO:0009310) | 3.19746251 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 3.19746251 |
| 97 | linoleic acid metabolic process (GO:0043651) | 3.19730956 |
| 98 | regulation of coenzyme metabolic process (GO:0051196) | 3.18088376 |
| 99 | regulation of cofactor metabolic process (GO:0051193) | 3.18088376 |
| 100 | protein-lipid complex subunit organization (GO:0071825) | 3.17926111 |
| 101 | ketone body metabolic process (GO:1902224) | 3.16437817 |
| 102 | branched-chain amino acid metabolic process (GO:0009081) | 3.16235150 |
| 103 | low-density lipoprotein particle clearance (GO:0034383) | 3.15875407 |
| 104 | indolalkylamine metabolic process (GO:0006586) | 3.14633177 |
| 105 | COPII vesicle coating (GO:0048208) | 3.14145197 |
| 106 | bile acid and bile salt transport (GO:0015721) | 3.13641092 |
| 107 | thioester metabolic process (GO:0035383) | 3.12684315 |
| 108 | acyl-CoA metabolic process (GO:0006637) | 3.12684315 |
| 109 | protein-lipid complex assembly (GO:0065005) | 3.11525518 |
| 110 | mitotic G2/M transition checkpoint (GO:0044818) | 3.11114231 |
| 111 | protein localization to kinetochore (GO:0034501) | 3.10842042 |
| 112 | acylglycerol catabolic process (GO:0046464) | 3.09793346 |
| 113 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.07784337 |
| 114 | carnitine shuttle (GO:0006853) | 2.98232933 |
| 115 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.97183209 |
| 116 | regulation of sulfur metabolic process (GO:0042762) | 2.96695555 |
| 117 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.85827381 |
| 118 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.85056060 |
| 119 | dorsal/ventral axis specification (GO:0009950) | 2.81284455 |
| 120 | response to lipoprotein particle (GO:0055094) | 2.80265393 |
| 121 | anterior/posterior axis specification, embryo (GO:0008595) | 2.78255305 |
| 122 | tricarboxylic acid cycle (GO:0006099) | 2.72589182 |
| 123 | female gonad development (GO:0008585) | 2.69489194 |
| 124 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.67246296 |
| 125 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.67246296 |
| 126 | DNA double-strand break processing (GO:0000729) | 2.66585743 |
| 127 | intracellular lipid transport (GO:0032365) | 2.66027996 |
| 128 | genitalia morphogenesis (GO:0035112) | 2.63381290 |
| 129 | regulation of centriole replication (GO:0046599) | 2.62205615 |
| 130 | triglyceride catabolic process (GO:0019433) | 2.62197404 |
| 131 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.61670796 |
| 132 | sister chromatid segregation (GO:0000819) | 2.60309393 |
| 133 | response to nitrosative stress (GO:0051409) | 2.59806947 |
| 134 | replication fork processing (GO:0031297) | 2.58817215 |
| 135 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.58062574 |
| 136 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.57693347 |
| 137 | neutral lipid catabolic process (GO:0046461) | 2.53099516 |
| 138 | protein localization to chromosome, centromeric region (GO:0071459) | 2.52103796 |
| 139 | pore complex assembly (GO:0046931) | 2.51838297 |
| 140 | L-serine metabolic process (GO:0006563) | 2.50697002 |
| 141 | regulation of centrosome cycle (GO:0046605) | 2.50301468 |
| 142 | regulation of centrosome duplication (GO:0010824) | 2.50172721 |
| 143 | positive regulation of glycolytic process (GO:0045821) | 2.46752782 |
| 144 | mitotic sister chromatid cohesion (GO:0007064) | 2.46114337 |
| 145 | coenzyme A metabolic process (GO:0015936) | 2.45397090 |
| 146 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.45117423 |
| 147 | chromatin remodeling at centromere (GO:0031055) | 2.44566774 |
| 148 | DNA strand renaturation (GO:0000733) | 2.43996897 |
| 149 | neurotransmitter catabolic process (GO:0042135) | 2.43584913 |
| 150 | non-recombinational repair (GO:0000726) | 2.43349835 |
| 151 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.43349835 |
| 152 | amino acid activation (GO:0043038) | 2.42344670 |
| 153 | tRNA aminoacylation (GO:0043039) | 2.42344670 |
| 154 | amino-acid betaine transport (GO:0015838) | 2.40897154 |
| 155 | carnitine transport (GO:0015879) | 2.40897154 |
| 156 | mitotic metaphase plate congression (GO:0007080) | 2.40463164 |
| 157 | intestinal absorption (GO:0050892) | 2.40319443 |
| 158 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.39295550 |
| 159 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.39295550 |
| 160 | CENP-A containing nucleosome assembly (GO:0034080) | 2.39290109 |
| 161 | tRNA aminoacylation for protein translation (GO:0006418) | 2.39064622 |
| 162 | zinc ion transport (GO:0006829) | 2.38694867 |
| 163 | regulation of translational fidelity (GO:0006450) | 2.38291266 |
| 164 | purine nucleobase biosynthetic process (GO:0009113) | 2.37658710 |
| 165 | negative regulation of DNA recombination (GO:0045910) | 2.37558679 |
| 166 | metaphase plate congression (GO:0051310) | 2.36318646 |
| 167 | intestinal cholesterol absorption (GO:0030299) | 2.36287871 |
| 168 | mitochondrial RNA metabolic process (GO:0000959) | 2.36231712 |
| 169 | mitotic sister chromatid segregation (GO:0000070) | 2.36184177 |
| 170 | regulation of sister chromatid cohesion (GO:0007063) | 2.31288818 |
| 171 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.31239778 |
| 172 | tetrahydrofolate metabolic process (GO:0046653) | 2.31009192 |
| 173 | mitochondrial DNA replication (GO:0006264) | 2.30935138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.29970250 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99734672 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.96519257 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.05304273 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.90691274 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.28648729 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.12646525 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.88059470 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.76035365 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.22765069 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.91629929 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.71661479 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.52973125 |
| 14 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.43330505 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.40265558 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.37919189 |
| 17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.28875875 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.26165332 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.11424482 |
| 20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.08926283 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.04956753 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02477940 |
| 23 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.93708521 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.91564929 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90078890 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88806055 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87027015 |
| 28 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.86132273 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.79379320 |
| 30 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76951840 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.71563696 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65677784 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.63017201 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.58215368 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54651580 |
| 36 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52772417 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52721699 |
| 38 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.51339032 |
| 39 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50122563 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48520797 |
| 41 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47035496 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.44001020 |
| 43 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.36649334 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36631508 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35940280 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.34459896 |
| 47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33157146 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32519754 |
| 49 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31827343 |
| 50 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.31797964 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31675190 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.30581541 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28196939 |
| 54 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.27670930 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26699330 |
| 56 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25615479 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25279648 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25125159 |
| 59 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.23458968 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23136309 |
| 61 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22832618 |
| 62 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21739454 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21632751 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21632751 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20823870 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19899991 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18417143 |
| 68 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16639342 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16170290 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15693091 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15014689 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14539236 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12561535 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.12521324 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10477755 |
| 76 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09120591 |
| 77 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08867839 |
| 78 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08687659 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07511185 |
| 80 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07329177 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07031392 |
| 82 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.06220438 |
| 83 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05295629 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04895545 |
| 85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04689313 |
| 86 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.04378660 |
| 87 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.04337192 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03571235 |
| 89 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02401839 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02227567 |
| 91 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02177700 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01112629 |
| 93 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01013967 |
| 94 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00756238 |
| 95 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00133594 |
| 96 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.99985482 |
| 97 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99827162 |
| 98 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99748525 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98800005 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97334624 |
| 101 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96819445 |
| 102 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96518408 |
| 103 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94814218 |
| 104 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94755574 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94524131 |
| 106 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94317681 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94073669 |
| 108 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93660704 |
| 109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92692322 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91682001 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91418455 |
| 112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91399334 |
| 113 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90097381 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89161373 |
| 115 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88480997 |
| 116 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88135059 |
| 117 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85006473 |
| 118 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84700172 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83927823 |
| 120 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.82210878 |
| 121 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.81933460 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81663351 |
| 123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79835617 |
| 124 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79546793 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79173436 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77632613 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77299526 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.74773844 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 0.74402950 |
| 130 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.74103755 |
| 131 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73601210 |
| 132 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73492680 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73460224 |
| 134 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.73460079 |
| 135 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73137165 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72572848 |
| 137 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71640169 |
| 138 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70556368 |
| 139 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.70231475 |
| 140 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.70026614 |
| 141 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.70019787 |
| 142 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.70019787 |
| 143 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.69618286 |
| 144 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.69452877 |
| 145 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.68913219 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68870698 |
| 147 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.68031259 |
| 148 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.67993530 |
| 149 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.67839971 |
| 150 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.67702008 |
| 151 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.67470680 |
| 152 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67450194 |
| 153 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.66746864 |
| 154 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.66252256 |
| 155 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.65050645 |
| 156 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64935217 |
| 157 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63920116 |
| 158 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.63563436 |
| 159 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.63563436 |
| 160 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.63531740 |
| 161 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63426966 |
| 162 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.62491275 |
| 163 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.62458743 |
| 164 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.62423688 |
| 165 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62216893 |
| 166 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61850479 |
| 167 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.60595672 |
| 168 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.60202693 |
| 169 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.59730742 |
| 170 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.59720449 |
| 171 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59411322 |
| 172 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.59403740 |
| 173 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.58893455 |
| 174 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.58680192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.84614391 |
| 2 | MP0005360_urolithiasis | 6.22511325 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.17845373 |
| 4 | MP0005365_abnormal_bile_salt | 5.17116537 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.98345946 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 3.70176782 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.57189370 |
| 8 | MP0003252_abnormal_bile_duct | 3.23954495 |
| 9 | MP0008057_abnormal_DNA_replication | 2.91090137 |
| 10 | MP0009840_abnormal_foam_cell | 2.83230920 |
| 11 | MP0005332_abnormal_amino_acid | 2.80257899 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.68585805 |
| 13 | MP0005670_abnormal_white_adipose | 2.56013100 |
| 14 | MP0003195_calcinosis | 2.54452012 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.54006470 |
| 16 | MP0003941_abnormal_skin_development | 2.50952910 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.33546243 |
| 18 | MP0006054_spinal_hemorrhage | 2.30021920 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.26877601 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.25464652 |
| 21 | MP0005083_abnormal_biliary_tract | 2.23386945 |
| 22 | MP0010094_abnormal_chromosome_stability | 2.20623586 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 2.16371780 |
| 24 | MP0004130_abnormal_muscle_cell | 2.13191904 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.07469503 |
| 26 | MP0000609_abnormal_liver_physiology | 2.02192549 |
| 27 | MP0003693_abnormal_embryo_hatching | 2.00547645 |
| 28 | MP0004272_abnormal_basement_membrane | 1.95468271 |
| 29 | MP0003690_abnormal_glial_cell | 1.79215684 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.74703726 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.73333442 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.71861089 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.67248335 |
| 34 | MP0004147_increased_porphyrin_level | 1.64549229 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.62272385 |
| 36 | MP0003937_abnormal_limbs/digits/tail_de | 1.59270759 |
| 37 | MP0003718_maternal_effect | 1.56933173 |
| 38 | MP0001764_abnormal_homeostasis | 1.56023088 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.55164086 |
| 40 | MP0008058_abnormal_DNA_repair | 1.55016448 |
| 41 | MP0005535_abnormal_body_temperature | 1.52005004 |
| 42 | MP0003111_abnormal_nucleus_morphology | 1.49829303 |
| 43 | MP0001293_anophthalmia | 1.47056927 |
| 44 | MP0003011_delayed_dark_adaptation | 1.45912092 |
| 45 | MP0005408_hypopigmentation | 1.42637892 |
| 46 | MP0002009_preneoplasia | 1.41800593 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.40965031 |
| 48 | MP0000604_amyloidosis | 1.40911080 |
| 49 | MP0005380_embryogenesis_phenotype | 1.39484478 |
| 50 | MP0001672_abnormal_embryogenesis/_devel | 1.39484478 |
| 51 | MP0000647_abnormal_sebaceous_gland | 1.37955393 |
| 52 | MP0008932_abnormal_embryonic_tissue | 1.36810468 |
| 53 | MP0002971_abnormal_brown_adipose | 1.35643063 |
| 54 | MP0002088_abnormal_embryonic_growth/wei | 1.35551379 |
| 55 | MP0003868_abnormal_feces_composition | 1.35507376 |
| 56 | MP0003984_embryonic_growth_retardation | 1.35280691 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.34397209 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.31093399 |
| 59 | MP0004043_abnormal_pH_regulation | 1.28936443 |
| 60 | MP0009703_decreased_birth_body | 1.28926539 |
| 61 | MP0002084_abnormal_developmental_patter | 1.22588345 |
| 62 | MP0009672_abnormal_birth_weight | 1.22262888 |
| 63 | MP0002233_abnormal_nose_morphology | 1.21949738 |
| 64 | MP0001730_embryonic_growth_arrest | 1.20821214 |
| 65 | MP0003329_amyloid_beta_deposits | 1.20649568 |
| 66 | MP0003077_abnormal_cell_cycle | 1.20421955 |
| 67 | MP0005334_abnormal_fat_pad | 1.18656723 |
| 68 | MP0003186_abnormal_redox_activity | 1.17868363 |
| 69 | MP0002102_abnormal_ear_morphology | 1.17242081 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.17039792 |
| 71 | MP0002697_abnormal_eye_size | 1.16201299 |
| 72 | MP0001697_abnormal_embryo_size | 1.14180442 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.11776631 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.07404029 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 1.06484534 |
| 76 | MP0001756_abnormal_urination | 1.06474121 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 1.05781244 |
| 78 | MP0003786_premature_aging | 1.04784475 |
| 79 | MP0003119_abnormal_digestive_system | 1.04594269 |
| 80 | MP0003950_abnormal_plasma_membrane | 1.04001944 |
| 81 | MP0001661_extended_life_span | 1.03864811 |
| 82 | MP0002638_abnormal_pupillary_reflex | 1.01723291 |
| 83 | MP0002086_abnormal_extraembryonic_tissu | 1.01443097 |
| 84 | MP0002111_abnormal_tail_morphology | 1.01417838 |
| 85 | MP0005375_adipose_tissue_phenotype | 1.00929176 |
| 86 | MP0008007_abnormal_cellular_replicative | 1.00820660 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 1.00745175 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 1.00731552 |
| 89 | MP0009384_cardiac_valve_regurgitation | 0.98815079 |
| 90 | MP0001286_abnormal_eye_development | 0.98030678 |
| 91 | MP0010678_abnormal_skin_adnexa | 0.97440368 |
| 92 | MP0002938_white_spotting | 0.97431830 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.96911077 |
| 94 | MP0009115_abnormal_fat_cell | 0.96397714 |
| 95 | MP0009697_abnormal_copulation | 0.96322612 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 0.95645830 |
| 97 | MP0000372_irregular_coat_pigmentation | 0.94607871 |
| 98 | MP0003122_maternal_imprinting | 0.94178084 |
| 99 | MP0003385_abnormal_body_wall | 0.93843717 |
| 100 | MP0005448_abnormal_energy_balance | 0.93650848 |
| 101 | MP0005187_abnormal_penis_morphology | 0.93540358 |
| 102 | MP0004197_abnormal_fetal_growth/weight/ | 0.91692911 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.91284003 |
| 104 | MP0003283_abnormal_digestive_organ | 0.90209518 |
| 105 | MP0008995_early_reproductive_senescence | 0.89313732 |
| 106 | MP0009764_decreased_sensitivity_to | 0.88313658 |
| 107 | MP0000598_abnormal_liver_morphology | 0.88253915 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.88103092 |
| 109 | MP0002254_reproductive_system_inflammat | 0.88097570 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.87720822 |
| 111 | MP0003075_altered_response_to | 0.87468954 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.87449782 |
| 113 | MP0003633_abnormal_nervous_system | 0.86907052 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.86136348 |
| 115 | MP0005647_abnormal_sex_gland | 0.85760955 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.85060773 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.84434233 |
| 118 | MP0002085_abnormal_embryonic_tissue | 0.84291797 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.83529654 |
| 120 | MP0002090_abnormal_vision | 0.82999622 |
| 121 | MP0005367_renal/urinary_system_phenotyp | 0.82087531 |
| 122 | MP0000516_abnormal_urinary_system | 0.82087531 |
| 123 | MP0009763_increased_sensitivity_to | 0.80823869 |
| 124 | MP0005451_abnormal_body_composition | 0.80586827 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.80336627 |
| 126 | MP0008877_abnormal_DNA_methylation | 0.78431097 |
| 127 | MP0004885_abnormal_endolymph | 0.78169126 |
| 128 | MP0008469_abnormal_protein_level | 0.77322931 |
| 129 | MP0003705_abnormal_hypodermis_morpholog | 0.77157811 |
| 130 | MP0002080_prenatal_lethality | 0.76571813 |
| 131 | MP0010307_abnormal_tumor_latency | 0.75861675 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.74855610 |
| 133 | MP0005395_other_phenotype | 0.74473817 |
| 134 | MP0001915_intracranial_hemorrhage | 0.73900015 |
| 135 | MP0003724_increased_susceptibility_to | 0.73101121 |
| 136 | MP0003935_abnormal_craniofacial_develop | 0.72030177 |
| 137 | MP0005253_abnormal_eye_physiology | 0.70546100 |
| 138 | MP0000383_abnormal_hair_follicle | 0.69836015 |
| 139 | MP0001501_abnormal_sleep_pattern | 0.69366039 |
| 140 | MP0003953_abnormal_hormone_level | 0.69086174 |
| 141 | MP0008872_abnormal_physiological_respon | 0.68200592 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.65002928 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.64116622 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.63642194 |
| 145 | MP0001881_abnormal_mammary_gland | 0.63568354 |
| 146 | MP0002970_abnormal_white_adipose | 0.61802272 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.61477499 |
| 148 | MP0008874_decreased_physiological_sensi | 0.61275790 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.60516096 |
| 150 | MP0005266_abnormal_metabolism | 0.59366909 |
| 151 | MP0003959_abnormal_lean_body | 0.58754797 |
| 152 | MP0005551_abnormal_eye_electrophysiolog | 0.58545121 |
| 153 | MP0000639_abnormal_adrenal_gland | 0.56982143 |
| 154 | MP0003638_abnormal_response/metabolism_ | 0.55639722 |
| 155 | MP0005166_decreased_susceptibility_to | 0.55317863 |
| 156 | MP0006082_CNS_inflammation | 0.55092567 |
| 157 | MP0003631_nervous_system_phenotype | 0.55011928 |
| 158 | MP0005452_abnormal_adipose_tissue | 0.52792711 |
| 159 | MP0004782_abnormal_surfactant_physiolog | 0.51730146 |
| 160 | MP0001765_abnormal_ion_homeostasis | 0.50453901 |
| 161 | MP0005646_abnormal_pituitary_gland | 0.48808490 |
| 162 | MP0005379_endocrine/exocrine_gland_phen | 0.48211993 |
| 163 | MP0005220_abnormal_exocrine_pancreas | 0.47777359 |
| 164 | MP0005464_abnormal_platelet_physiology | 0.46934135 |
| 165 | MP0002069_abnormal_eating/drinking_beha | 0.46200180 |
| 166 | MP0002229_neurodegeneration | 0.44298695 |
| 167 | MP0000920_abnormal_myelination | 0.43676671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.70663386 |
| 2 | Xanthomatosis (HP:0000991) | 5.38280114 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.18742691 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.12189764 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 4.74402991 |
| 6 | Complement deficiency (HP:0004431) | 4.65568785 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.58038904 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.43809301 |
| 9 | Hyperglycinuria (HP:0003108) | 4.41996882 |
| 10 | Ketosis (HP:0001946) | 4.33302475 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.29199769 |
| 12 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.27349140 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.25380710 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.25380710 |
| 15 | Epidermoid cyst (HP:0200040) | 4.22202829 |
| 16 | Hyperammonemia (HP:0001987) | 4.16101690 |
| 17 | Hyperglycinemia (HP:0002154) | 4.14199113 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.10471138 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.94083013 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.86632775 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.83751623 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81621124 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.80390086 |
| 24 | Ketoacidosis (HP:0001993) | 3.64539291 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64366122 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.52899200 |
| 27 | Abnormality of glycolysis (HP:0004366) | 3.51014232 |
| 28 | Joint hemorrhage (HP:0005261) | 3.46630725 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.35246260 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.28927637 |
| 31 | Chromsome breakage (HP:0040012) | 3.27876861 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.23656278 |
| 33 | Abnormality of complement system (HP:0005339) | 3.17504757 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.16677254 |
| 35 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.12168854 |
| 36 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.12168854 |
| 37 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.12098571 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 3.09029747 |
| 39 | Fat malabsorption (HP:0002630) | 3.04777446 |
| 40 | Abnormality of alanine metabolism (HP:0010916) | 2.95631579 |
| 41 | Hyperalaninemia (HP:0003348) | 2.95631579 |
| 42 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.95631579 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.90729452 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.85962861 |
| 45 | Dicarboxylic aciduria (HP:0003215) | 2.85962861 |
| 46 | Embryonal renal neoplasm (HP:0011794) | 2.83470869 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.78786048 |
| 48 | Skin nodule (HP:0200036) | 2.73899257 |
| 49 | Abnormality of chromosome stability (HP:0003220) | 2.73775065 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.73482795 |
| 51 | Gout (HP:0001997) | 2.72723283 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.72625922 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.69890921 |
| 54 | Bifid tongue (HP:0010297) | 2.65183283 |
| 55 | Metabolic acidosis (HP:0001942) | 2.63765229 |
| 56 | Hydroxyprolinuria (HP:0003080) | 2.63752185 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 2.63752185 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.59816241 |
| 59 | Myocardial infarction (HP:0001658) | 2.55198713 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.54200227 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.53446680 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.50743190 |
| 63 | Lethargy (HP:0001254) | 2.45181054 |
| 64 | Hyperbilirubinemia (HP:0002904) | 2.42627820 |
| 65 | Cerebral edema (HP:0002181) | 2.42354684 |
| 66 | Amyloidosis (HP:0011034) | 2.40955118 |
| 67 | Vascular calcification (HP:0004934) | 2.40160823 |
| 68 | Glomerulonephritis (HP:0000099) | 2.40155906 |
| 69 | Meckel diverticulum (HP:0002245) | 2.40053467 |
| 70 | Pigmentary retinal degeneration (HP:0001146) | 2.37110911 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 2.34508800 |
| 72 | Hepatoblastoma (HP:0002884) | 2.34113780 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.33926024 |
| 74 | Abnormality of the ileum (HP:0001549) | 2.32413303 |
| 75 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.32043153 |
| 76 | Anal stenosis (HP:0002025) | 2.30559764 |
| 77 | Hypertriglyceridemia (HP:0002155) | 2.27574427 |
| 78 | Brushfield spots (HP:0001088) | 2.22250963 |
| 79 | Irritability (HP:0000737) | 2.20907239 |
| 80 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.20846428 |
| 81 | Absent eyebrow (HP:0002223) | 2.19444856 |
| 82 | Rhabdomyosarcoma (HP:0002859) | 2.18925642 |
| 83 | Steatorrhea (HP:0002570) | 2.18687856 |
| 84 | Neurofibrillary tangles (HP:0002185) | 2.17758362 |
| 85 | Vomiting (HP:0002013) | 2.16895553 |
| 86 | Volvulus (HP:0002580) | 2.15459968 |
| 87 | Pancreatitis (HP:0001733) | 2.15195232 |
| 88 | Myelomeningocele (HP:0002475) | 2.13398893 |
| 89 | Hyperuricemia (HP:0002149) | 2.12925068 |
| 90 | Increased purine levels (HP:0004368) | 2.12925068 |
| 91 | Mitral stenosis (HP:0001718) | 2.12317845 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.11469088 |
| 93 | Myoglobinuria (HP:0002913) | 2.07403855 |
| 94 | Neoplasm of the adrenal gland (HP:0100631) | 2.06818771 |
| 95 | Oligomenorrhea (HP:0000876) | 2.04140044 |
| 96 | Abnormal lung lobation (HP:0002101) | 2.04047154 |
| 97 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.03575545 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02936093 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.02332112 |
| 100 | Alkalosis (HP:0001948) | 2.02241519 |
| 101 | Late onset (HP:0003584) | 2.00242797 |
| 102 | Proximal tubulopathy (HP:0000114) | 1.99598846 |
| 103 | Cortical dysplasia (HP:0002539) | 1.98456872 |
| 104 | Facial shape deformation (HP:0011334) | 1.95474832 |
| 105 | Potter facies (HP:0002009) | 1.95474832 |
| 106 | Cholecystitis (HP:0001082) | 1.95236470 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 1.95236470 |
| 108 | Short tibia (HP:0005736) | 1.95155438 |
| 109 | Abnormality of the parathyroid morphology (HP:0011766) | 1.94910001 |
| 110 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.94657472 |
| 111 | Renal cortical cysts (HP:0000803) | 1.94523110 |
| 112 | Cholelithiasis (HP:0001081) | 1.94455637 |
| 113 | Acanthocytosis (HP:0001927) | 1.94432517 |
| 114 | Disproportionate short-trunk short stature (HP:0003521) | 1.94251112 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 1.93308584 |
| 116 | Glycosuria (HP:0003076) | 1.93308584 |
| 117 | Abnormality of the preputium (HP:0100587) | 1.92330715 |
| 118 | Neonatal onset (HP:0003623) | 1.89139047 |
| 119 | Abnormality of the renal cortex (HP:0011035) | 1.88601696 |
| 120 | Clitoromegaly (HP:0000057) | 1.87289131 |
| 121 | Missing ribs (HP:0000921) | 1.87248324 |
| 122 | Retinal atrophy (HP:0001105) | 1.87018956 |
| 123 | Abnormal pancreas size (HP:0012094) | 1.86794913 |
| 124 | Spontaneous abortion (HP:0005268) | 1.84840319 |
| 125 | Hypophosphatemic rickets (HP:0004912) | 1.83686317 |
| 126 | Hyperglycemia (HP:0003074) | 1.82968589 |
| 127 | Hemorrhage of the eye (HP:0011885) | 1.82940125 |
| 128 | Vaginal fistula (HP:0004320) | 1.82100300 |
| 129 | Status epilepticus (HP:0002133) | 1.81927296 |
| 130 | Absent radius (HP:0003974) | 1.81649435 |
| 131 | Nausea (HP:0002018) | 1.80802881 |
| 132 | Colon cancer (HP:0003003) | 1.80442398 |
| 133 | Cerebral inclusion bodies (HP:0100314) | 1.80246559 |
| 134 | Enlarged kidneys (HP:0000105) | 1.79348973 |
| 135 | Methylmalonic aciduria (HP:0012120) | 1.78207145 |
| 136 | Acute hepatic failure (HP:0006554) | 1.77539555 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77490818 |
| 138 | Symptomatic seizures (HP:0011145) | 1.77006329 |
| 139 | Biliary tract neoplasm (HP:0100574) | 1.76377157 |
| 140 | Papillary thyroid carcinoma (HP:0002895) | 1.76254647 |
| 141 | Rectovaginal fistula (HP:0000143) | 1.76024874 |
| 142 | Rectal fistula (HP:0100590) | 1.76024874 |
| 143 | Sloping forehead (HP:0000340) | 1.74246326 |
| 144 | Breast carcinoma (HP:0003002) | 1.73541972 |
| 145 | Ovarian neoplasm (HP:0100615) | 1.72835596 |
| 146 | Gonadotropin excess (HP:0000837) | 1.72549326 |
| 147 | Duodenal stenosis (HP:0100867) | 1.72434965 |
| 148 | Small intestinal stenosis (HP:0012848) | 1.72434965 |
| 149 | Epiphyseal stippling (HP:0010655) | 1.68870004 |
| 150 | Aplasia involving forearm bones (HP:0009822) | 1.67402245 |
| 151 | Absent forearm bone (HP:0003953) | 1.67402245 |
| 152 | Abnormality of the duodenum (HP:0002246) | 1.67076139 |
| 153 | Subcapsular cataract (HP:0000523) | 1.66298109 |
| 154 | Abnormality of the lumbar spine (HP:0100712) | 1.64624025 |
| 155 | Genital tract atresia (HP:0001827) | 1.64042751 |
| 156 | Megaloblastic anemia (HP:0001889) | 1.63654039 |
| 157 | Abnormal tarsal ossification (HP:0008369) | 1.62111750 |
| 158 | Thyroid carcinoma (HP:0002890) | 1.61691613 |
| 159 | Hypoplastic pelvis (HP:0008839) | 1.61030739 |
| 160 | Embryonal neoplasm (HP:0002898) | 1.60087320 |
| 161 | Septate vagina (HP:0001153) | 1.59334002 |
| 162 | Abnormal biliary tract morphology (HP:0012440) | 1.59225460 |
| 163 | Hypothermia (HP:0002045) | 1.57035145 |
| 164 | Vaginal atresia (HP:0000148) | 1.55676913 |
| 165 | Tubulointerstitial nephritis (HP:0001970) | 1.54821862 |
| 166 | Glioma (HP:0009733) | 1.53651331 |
| 167 | Median cleft lip (HP:0000161) | 1.53433141 |
| 168 | Tubular atrophy (HP:0000092) | 1.52271335 |
| 169 | Bicornuate uterus (HP:0000813) | 1.51864932 |
| 170 | Neoplasm of the small intestine (HP:0100833) | 1.51172451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.52075748 |
| 2 | ACVR1B | 3.90384231 |
| 3 | SIK1 | 3.46345969 |
| 4 | MST4 | 3.20578234 |
| 5 | CAMK1D | 3.05381014 |
| 6 | ERN1 | 2.91017003 |
| 7 | INSRR | 2.82198098 |
| 8 | TTK | 2.60506874 |
| 9 | TSSK6 | 2.55224444 |
| 10 | EIF2AK3 | 2.47745792 |
| 11 | BMPR1B | 2.38716487 |
| 12 | PBK | 2.32740341 |
| 13 | AKT3 | 2.28446192 |
| 14 | BCR | 2.13737042 |
| 15 | CAMK1G | 2.13532086 |
| 16 | SRPK1 | 2.05193989 |
| 17 | ZAK | 2.04820758 |
| 18 | EIF2AK1 | 2.04431249 |
| 19 | TNIK | 2.02736714 |
| 20 | MKNK2 | 1.99973382 |
| 21 | TRIM28 | 1.98148644 |
| 22 | STK3 | 1.98031658 |
| 23 | TAOK3 | 1.95918199 |
| 24 | BRSK2 | 1.91302353 |
| 25 | FGFR4 | 1.88618502 |
| 26 | NEK1 | 1.86021526 |
| 27 | MKNK1 | 1.81239308 |
| 28 | DAPK2 | 1.80259804 |
| 29 | MAP2K4 | 1.77288156 |
| 30 | PLK3 | 1.75960040 |
| 31 | NUAK1 | 1.74702152 |
| 32 | TRIB3 | 1.70743973 |
| 33 | PLK4 | 1.66584412 |
| 34 | PDK2 | 1.58478460 |
| 35 | MST1R | 1.54397798 |
| 36 | BUB1 | 1.47003312 |
| 37 | PDK4 | 1.46871729 |
| 38 | PDK3 | 1.46871729 |
| 39 | STK38L | 1.44489769 |
| 40 | FRK | 1.44450232 |
| 41 | FGFR1 | 1.44033694 |
| 42 | PRKAA2 | 1.42294774 |
| 43 | WEE1 | 1.41814366 |
| 44 | WNK4 | 1.41129155 |
| 45 | OXSR1 | 1.37412008 |
| 46 | PKN2 | 1.34645850 |
| 47 | ERBB4 | 1.33597323 |
| 48 | TGFBR2 | 1.32920928 |
| 49 | MAPK12 | 1.32378706 |
| 50 | MAP3K13 | 1.32332106 |
| 51 | LMTK2 | 1.31612517 |
| 52 | NEK9 | 1.30943294 |
| 53 | ERBB3 | 1.25267675 |
| 54 | PINK1 | 1.23240186 |
| 55 | MAPK11 | 1.14056445 |
| 56 | NTRK1 | 1.13720149 |
| 57 | PLK1 | 1.11656998 |
| 58 | JAK1 | 1.07905107 |
| 59 | JAK2 | 1.06777976 |
| 60 | WNK3 | 1.06554786 |
| 61 | PDPK1 | 1.04694388 |
| 62 | NEK2 | 1.04465212 |
| 63 | STK39 | 1.02963849 |
| 64 | MAP4K2 | 1.02905105 |
| 65 | LATS1 | 1.02744589 |
| 66 | FLT3 | 1.02616609 |
| 67 | RIPK4 | 1.01439721 |
| 68 | CAMKK1 | 1.00741987 |
| 69 | MAPK15 | 1.00384457 |
| 70 | SGK494 | 0.99848892 |
| 71 | SGK223 | 0.99848892 |
| 72 | IRAK3 | 0.99758689 |
| 73 | CDC7 | 0.99172946 |
| 74 | RIPK1 | 0.98633228 |
| 75 | PIK3CG | 0.97102273 |
| 76 | TAF1 | 0.94891877 |
| 77 | MAP3K12 | 0.94678168 |
| 78 | PDK1 | 0.94614072 |
| 79 | CSNK1G1 | 0.92839191 |
| 80 | FGFR2 | 0.92593970 |
| 81 | MAP3K7 | 0.92576675 |
| 82 | SGK3 | 0.90790888 |
| 83 | PASK | 0.90768510 |
| 84 | PRKAA1 | 0.87903815 |
| 85 | EPHB1 | 0.86894877 |
| 86 | SGK2 | 0.83241573 |
| 87 | RPS6KB2 | 0.83004952 |
| 88 | PRKCZ | 0.82559888 |
| 89 | RET | 0.79704406 |
| 90 | PRKACG | 0.79268310 |
| 91 | ATM | 0.76539133 |
| 92 | ATR | 0.76388710 |
| 93 | EEF2K | 0.76182974 |
| 94 | MET | 0.73563549 |
| 95 | KSR2 | 0.73284494 |
| 96 | CASK | 0.73264423 |
| 97 | FGFR3 | 0.72670351 |
| 98 | TYK2 | 0.72572158 |
| 99 | LATS2 | 0.71886318 |
| 100 | VRK1 | 0.71651834 |
| 101 | IGF1R | 0.71552425 |
| 102 | MAP3K9 | 0.70780572 |
| 103 | TGFBR1 | 0.69814914 |
| 104 | EIF2AK2 | 0.69767691 |
| 105 | NLK | 0.69295982 |
| 106 | MAPK7 | 0.67504860 |
| 107 | PHKG2 | 0.67359510 |
| 108 | PHKG1 | 0.67359510 |
| 109 | MAPK4 | 0.66878421 |
| 110 | PTK6 | 0.66869119 |
| 111 | YES1 | 0.66166787 |
| 112 | PIK3CA | 0.63117564 |
| 113 | CHEK2 | 0.62598878 |
| 114 | STK38 | 0.61966366 |
| 115 | GSK3A | 0.61703669 |
| 116 | MUSK | 0.61058472 |
| 117 | ABL2 | 0.60291476 |
| 118 | MAPK13 | 0.60168837 |
| 119 | PRKCH | 0.59713364 |
| 120 | MAP3K4 | 0.58871035 |
| 121 | EPHA4 | 0.58059728 |
| 122 | SCYL2 | 0.57833543 |
| 123 | GRK1 | 0.57450104 |
| 124 | CAMKK2 | 0.57407835 |
| 125 | MAP2K7 | 0.57248967 |
| 126 | MAP3K14 | 0.55892188 |
| 127 | MAP2K1 | 0.55739477 |
| 128 | GRK7 | 0.55348830 |
| 129 | TBK1 | 0.54886322 |
| 130 | CDK3 | 0.54254605 |
| 131 | DYRK3 | 0.53363162 |
| 132 | PAK3 | 0.52699312 |
| 133 | RPS6KA4 | 0.52409598 |
| 134 | TNK2 | 0.52145877 |
| 135 | MAP3K6 | 0.50453399 |
| 136 | CSF1R | 0.49165181 |
| 137 | MINK1 | 0.48175030 |
| 138 | CAMK2G | 0.47793042 |
| 139 | SGK1 | 0.46894908 |
| 140 | AURKB | 0.46861659 |
| 141 | CHEK1 | 0.46472611 |
| 142 | CSNK1E | 0.46301468 |
| 143 | CSK | 0.46232474 |
| 144 | NTRK3 | 0.45843781 |
| 145 | STK4 | 0.45560511 |
| 146 | ERBB2 | 0.45529999 |
| 147 | TIE1 | 0.45393779 |
| 148 | MELK | 0.43930310 |
| 149 | MAP3K2 | 0.41416295 |
| 150 | PRKCE | 0.41086597 |
| 151 | PRKCQ | 0.40627574 |
| 152 | MAP3K1 | 0.40529736 |
| 153 | BRD4 | 0.40484776 |
| 154 | RPS6KB1 | 0.40320223 |
| 155 | GRK5 | 0.37921087 |
| 156 | CDK5 | 0.37311514 |
| 157 | CDK6 | 0.37271720 |
| 158 | PLK2 | 0.37161826 |
| 159 | CAMK2A | 0.35724076 |
| 160 | PRKCG | 0.35037529 |
| 161 | AKT2 | 0.34999320 |
| 162 | PRKDC | 0.34974191 |
| 163 | CDK1 | 0.34653538 |
| 164 | WNK1 | 0.34278632 |
| 165 | PKN1 | 0.33475923 |
| 166 | CSNK1A1L | 0.33459171 |
| 167 | PNCK | 0.33007341 |
| 168 | NEK6 | 0.32695926 |
| 169 | FER | 0.32319454 |
| 170 | STK10 | 0.31478110 |
| 171 | CDK7 | 0.29187445 |
| 172 | CSNK1A1 | 0.28932660 |
| 173 | CSNK2A1 | 0.27615171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59741289 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58392832 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.86503790 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.85209981 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.81662980 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69253490 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.67275732 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55513550 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52448242 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.50155702 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45806828 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40800877 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.35232808 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33519275 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.15417808 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.09355870 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.05072212 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.93258167 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.90570353 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.84159720 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83916833 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83050783 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82585707 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.79707001 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69882894 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69748595 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.65441156 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59780072 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56096120 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54335608 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54223484 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54012224 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51327780 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49668268 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.44857183 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44352614 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44249727 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43435556 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43368792 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.38454971 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33964952 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32965682 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.32638920 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30304400 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29301853 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29215281 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28225922 |
| 48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.23724577 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20597672 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18524112 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.18056976 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 1.17923856 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.17506931 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17250870 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.16858828 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14292907 |
| 57 | RNA transport_Homo sapiens_hsa03013 | 1.12261746 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02610562 |
| 59 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.96895861 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 0.95099770 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93560998 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91319511 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89156534 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88056717 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84372727 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.84207122 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.82656606 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81914236 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78380932 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76928277 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74916612 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.74387020 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71344337 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.70013258 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68900879 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67945328 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65431426 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63054781 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59571663 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59015033 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54731763 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53910085 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53829095 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53824978 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.53112968 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52745197 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52465847 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51268463 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.50577851 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49585555 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 0.47783825 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46144488 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43757804 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43617133 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43009376 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42990571 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42176235 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41346796 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.41200292 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40765541 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38827139 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38464788 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.35776395 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33133029 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32927240 |
| 106 | Spliceosome_Homo sapiens_hsa03040 | 0.32630948 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29758180 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29748321 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.29398289 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28238816 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26373706 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25264877 |
| 113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21516880 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20661640 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19876849 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19358121 |
| 117 | GABAergic synapse_Homo sapiens_hsa04727 | 0.17557851 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17382186 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16317821 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13114590 |
| 121 | Renin secretion_Homo sapiens_hsa04924 | 0.13098461 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12259833 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11905396 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.11783612 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07521720 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.05432861 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.03710662 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.03422039 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00600717 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00273230 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | -0.0273409 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0264424 |
| 133 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | -0.0230077 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0017423 |

